Chubb and Marsh develop $150mn Covax compensation scheme

Chubb and Marsh have structured a $150mn no-fault compensation scheme for citizens of 92 lower-income countries who suffer a serious adverse reaction to a Covid-19 vaccine.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com

      Chubb
      COVID-19
      Marsh